AC
ENTA icon

Armistice Capital’s Enanta Pharmaceuticals ENTA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000,000
Closed -$10.4M 255
2024
Q3
$10.4M Sell
1,000,000
-96,000
-9% -$995K 0.17% 89
2024
Q2
$14.2M Sell
1,096,000
-140,000
-11% -$1.82M 0.18% 77
2024
Q1
$21.6M Sell
1,236,000
-828,000
-40% -$14.5M 0.29% 61
2023
Q4
$19.4M Sell
2,064,000
-36,000
-2% -$339K 0.27% 59
2023
Q3
$23.5M Buy
2,100,000
+64,000
+3% +$715K 0.36% 47
2023
Q2
$43.6M Buy
2,036,000
+24,000
+1% +$514K 0.63% 32
2023
Q1
$81.4M Sell
2,012,000
-66,000
-3% -$2.67M 1.17% 15
2022
Q4
$96.7M Buy
2,078,000
+6,000
+0.3% +$279K 1.69% 11
2022
Q3
$107M Buy
2,072,000
+2,000
+0.1% +$104K 1.86% 8
2022
Q2
$97.8K Buy
2,070,000
+946,000
+84% +$44.7K 1.71% 10
2022
Q1
$80M Buy
1,124,000
+68,000
+6% +$4.84M 1.55% 10
2021
Q4
$79M Sell
1,056,000
-780,000
-42% -$58.3M 1.29% 12
2021
Q3
$104M Sell
1,836,000
-164,000
-8% -$9.32M 1.77% 7
2021
Q2
$88M Buy
2,000,000
+352,000
+21% +$15.5M 1.58% 9
2021
Q1
$81.3M Buy
1,648,000
+292,000
+22% +$14.4M 1.87% 8
2020
Q4
$57.1M Buy
1,356,000
+832,000
+159% +$35M 1.94% 10
2020
Q3
$24M Buy
524,000
+200,000
+62% +$9.16M 0.87% 41
2020
Q2
$16.3M Sell
324,000
-244,000
-43% -$12.3M 0.71% 48
2020
Q1
$29.2M Buy
568,000
+174,105
+44% +$8.95M 1.81% 17
2019
Q4
$24.3M Sell
393,895
-186,105
-32% -$11.5M 1.4% 18
2019
Q3
$34.8M Buy
580,000
+200,000
+53% +$12M 2.31% 9
2019
Q2
$32.1M Buy
380,000
+8,000
+2% +$675K 2.02% 13
2019
Q1
$35.5M Sell
372,000
-128,000
-26% -$12.2M 1.94% 11
2018
Q4
$35.4M Buy
500,000
+44,000
+10% +$3.12M 2.68% 7
2018
Q3
$39M Buy
456,000
+332,000
+268% +$28.4M 2.34% 7
2018
Q2
$14.4M Sell
124,000
-8,000
-6% -$927K 0.94% 27
2018
Q1
$10.7M Buy
132,000
+44,000
+50% +$3.56M 0.82% 36
2017
Q4
$5.16M Sell
88,000
-20,000
-19% -$1.17M 0.51% 46
2017
Q3
$5.05M Sell
108,000
-156,000
-59% -$7.3M 0.6% 41
2017
Q2
$9.5M Sell
264,000
-8,000
-3% -$288K 1.21% 32
2017
Q1
$8.38M Buy
272,000
+44,000
+19% +$1.36M 1.73% 22
2016
Q4
$7.64M Buy
228,000
+16,000
+8% +$536K 1.81% 26
2016
Q3
$5.64M Sell
212,000
-28,000
-12% -$745K 1.81% 20
2016
Q2
$5.29M Buy
+240,000
New +$5.29M 2.01% 19